Navigation Links
Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research

e following location:

http://www.abstractsonline.com/viewer/viewAbstractPrintFriendly.asp?CKey ={188066EA-1D6A-4A42-A0B8-0E27B5DA8D33}&SKey={F80F5B70-96B7-4FF9-A8FF-96 3E225CBA20}&MKey={E3F4019C-0A43-4514-8F66-B86DC90CD935}&AKey={728BCE9C-1 21B-46B9-A8EE-DC51FDFC6C15} <http://www.abstractsonline.com/viewer/viewAbstractPrintFriendly.asp?CKe y=%7b188066EA-1D6A-4A42-A0B8-0E27B5DA8D33%7d&SKey=%7bF80F5B70-96B7-4FF9- A8FF-963E225CBA20%7d&MKey=%7bE3F4019C-0A43-4514-8F66-B86DC90CD935%7d&AKe y=%7b728BCE9C-121B-46B9-A8EE-DC51FDFC6C15%7d>

About Santaris Pharma

Santaris Pharma is a clinical-stage biopharmaceutical company focused on developing a new class of RNAi drugs intended to switch off the expression of harmful genes. Called RNA Antagonists, these new drugs are being developed by Santaris and its corporate partners for the treatment of cancer and metabolic disorders. Created in May 2003 and backed by a broad group of leading international life science venture capital investors, Santaris Pharma completed a Euro 40m second round of equity financing in May 2006. In July 2006, the Company entered into a global partnership with Enzon Pharmaceuticals of New Jersey to co-develop and commercialise a series of Santaris RNA Antagonists for improving the treatment of cancer.

Santaris Pharma's RNA Antagonist drug pipeline is based on its unique Locked Nucleic Acid (LNA) technology. LNA drugs, with their high potency and biostability, have the potential to transform the field of RNAi medicines, making specific and effective gene silencing a reality in human medicine. If this potential is realised, even in part, it may be possible to design new drugs to treat the underlying genetic causes of disease rather than just the physical s
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:7/31/2014)... Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ), a ... today reported its financial results for the quarter ended June ... of 2014 to the same period of 2013: , ... , t:slim Pump shipments grew 64 percent to 2,235 ... ended June 30, 2014 to the same period of 2013: ...
(Date:7/31/2014)... SUNNYVALE, Calif. , July 31, 2014  Cepheid (NASDAQ: ... be speaking at the following conferences, and invited investors to ... Management Access Conference, New York, NY ... Baird Health Care Conference, New York, ... Eastern Time , Accessing Live Webcasts To access ...
(Date:7/31/2014)... --  Auxilium Pharmaceuticals , Inc. (NASDAQ: AUXL ... that the Company will release results for the second ... the opening of the U.S. financial markets. The Company ... 8:30 a.m. ET to discuss results and highlights of ... be used during the call will be available on ...
Breaking Medicine Technology:Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Cepheid to Webcast Upcoming Financial Presentations 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 3
... 22 CardioVascular,BioTherapeutics, Inc. (OTC Bulletin Board: CVBT) has ... be the sponsor and general,partner of ProDerm Limited Partnership ... up to $10 million of the clinical development for ... with CVBT,s wound healing drug, which I,believe has the ...
... Analysis of rEEG(R) Guided Medication Study Demonstrates an ... Improvement in Depression and Eating Disorder Symptoms, ... Inc.,(OTC Bulletin Board: CNSO) reported today the results ... (APA) 161st Annual Meeting by Dr.,James Greenblatt, M.D., ...
Cached Medicine Technology:Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 2Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 3CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 2CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 3CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 4CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 5CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 6
(Date:8/1/2014)... 2014 A new study published ... may contribute to the development of colorectal cancer in ... The study was authored by Alberto Martin of the ... cause intestinal cells to multiply and create tumors in ... , “What’s interesting about this study,” said Shahab ...
(Date:8/1/2014)... BellasDress has recently showcased its beautifully ... season’s gorgeous styles. The company’s lot of hot styles, ... outfits, one shoulder chiffon outfits and high low outfits. ... elegant purple prom dresses. As one of the most ... product quality. Thus, all its items are of superb ...
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, 2014 (HealthDay ... has a well-earned reputation as one of the world,s most ... medical care can greatly improve a person,s chances of survival. ... life-threatening havoc within the body by attacking multiple organ systems ... on the basics of "good meticulous intensive care," supporting the ...
(Date:8/1/2014)... For the first time, Textile ... & Fiber Report and the Organic Cotton Market Report ... cotton supply chain resulting in the 2013 Organic ... Director, reports, “We are looking holistically at the organic ... of a long value chain and surveying the entire ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 “When insulation ... throughout your entire home.“ In a newly released article ... Attic Insulation Needs To Be Replaced ,” Clean Crawls ... become damp, or been infested by critters. , ... quote from Clean Crawls - http://www.cleancrawl.com/contact . , ...
Breaking Medicine News(10 mins):Health News:Carbs May Contribute to Colon Cancer 2Health News:BellasDress Creates Must-have Purple Prom Dresses for Prom Attendees 2Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 2Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 3Health News:Surveys Reveal the Top 10 Organic Cotton Users and the Top 10 Producing Countries 2Health News:5 Signs That Insulation Should Be Replaced Detailed in a Newly Released Article By Clean Crawls 2
... TUESDAY, Jan. 25 (HealthDay News) -- There,s a worrisome uptick in ... even younger Americans, and some experts link the trend to a ... decades. That,s because the human papillomavirus (HPV) is a major ... type of sexual activity. "It seems like a pretty ...
... study, which was conducted at Sahlgrenska University Hospital in ... between the ages of 18 and 65. Half the ... and the other half to maintain their usual lifestyle. ... physiotherapist. The active group increased their physical activity on ...
... French researchers determined that infection with human immunodeficiency ... liver cancer, with more HIV infected patients dropping ... that overall survival and recurrence-free survival was not ... HIV disease. Details of this single center studythe ...
... HealthDay Reporter , MONDAY, Jan. 24 (HealthDay News) ... become the healthiest, wealthiest and most successful adults, new research ... 3 are more likely to drop out of school, break ... Researchers analyzed data on about 1,000 children born in ...
... As keyboards increasingly replace pens, new research cautions that the ... critical brain activity central to learning that is uniquely tied ... from the results of a number of experiments recently reviewed ... concluded that writing by hand is actually a very different ...
... Association of Clinical Endocrinologists (AACE) has released new medical ... Loyola physician Pauline Camacho, MD, was part of a ... public health issue. These recommendations were developed to ... quality of life for patients. They explain new treatment ...
Cached Medicine News:Health News:Rise in Some Head and Neck Cancers Tied to Oral Sex: Study 2Health News:Rise in Some Head and Neck Cancers Tied to Oral Sex: Study 3Health News:Rise in Some Head and Neck Cancers Tied to Oral Sex: Study 4Health News:Patients infected with HIV have higher drop-out rate for liver transplantation 2Health News:Self-Control Could Turn Kids Into Successful Adults 2Health News:Self-Control Could Turn Kids Into Successful Adults 3Health News:Pen Mightier Than Keyboard for Making Imprint on Brain 2Health News:Loyola physician helps develop national guidelines for osteoporosis 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: